ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Topic: PHI

A brief, discourging history of lap band surgery (the choice of Gov. Chris Christie)

A brief, discourging history of lap band surgery (the choice of Gov. Chris Christie)

May 7, 2013 10:35 pm by | 0 Comments

(Reuters) - New Jersey Governor Chris Christie's choice of gastric banding has prompted questions about why he opted for a weight-loss procedure less favored by bariatric surgeons and patients.Lap-Band stirred ... Read more
Nursing shortage’s impact in pediatrics: Study says NICUs need nurses

Nursing shortage’s impact in pediatrics: Study says NICUs need nurses

March 25, 2013 4:43 am by | 0 Comments

A surprising number of the nation's neonatal intensive care units (NICUs) have too few nurses, a new study by researchers from the University of Pennsylvania and the University of Medicine ... Read more
Generic drugmakers’ Supreme Court moment: Can pharma pay them to stay away?

Generic drugmakers’ Supreme Court moment: Can pharma pay them to stay away?

March 24, 2013 2:34 pm by | 0 Comments

The U.S. Supreme Court will hear arguments Monday in a case that affects the health and wallets of millions of Americans, most of whom know nothing about the contentious issue. ... Read more
Clinicals trial database including J&J, Lily, Merck will launch by year’s end

Clinicals trial database including J&J, Lily, Merck will launch by year’s end

November 15, 2012 9:30 am by | 0 Comments

Johnson & Johnson, Merck & Co Inc and Eli Lily & Co, plan to launch a one-stop database of global clinical trial sites aimed at streamlining paperwork and speeding the ... Read more
Look back at Merck’s earnings last week (and why they should excite you)

Look back at Merck’s earnings last week (and why they should excite you)

October 28, 2012 12:48 pm by | 0 Comments

Drugmaker Merck & Co. Inc. said its third-quarter profits rose 2 percent in part because it cut costs to offset generic competition against key products.Merck is based in Whitehouse Station, ... Read more
Celgene multiple myeloma cancer treatment passes a critical test

Celgene multiple myeloma cancer treatment passes a critical test

October 23, 2012 2:24 pm by | 0 Comments

(Reuters) - Independent safety monitors determined that Celgene Corp's experimental cancer drug met the main goal of a late stage trial of improving progression-free survival in multiple myeloma patients who ... Read more
FDA approves Eisai’s epilepsy treatment for seizures

FDA approves Eisai’s epilepsy treatment for seizures

October 22, 2012 5:20 pm by | 0 Comments

(Reuters) - U.S. health regulators approved Japanese drugmaker Eisai Co Ltd's Fycompa tablets to treat partial seizures in epileptic patients, saying current treatments on the market were unsatisfactory in controlling ... Read more
Rosetta Genomics add chief medical officer, chief scientific officer

Rosetta Genomics add chief medical officer, chief scientific officer

October 11, 2012 9:48 am by | 0 Comments

Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that E. Robert Wassman, M.D. and Dganit Bar, Ph.D. will join the Company in the ... Read more
Inovio cervical cancer treatment that retrains immune system gets good early results

Inovio cervical cancer treatment that retrains immune system gets good early results

October 10, 2012 4:55 pm by | 0 Comments

CHICAGO (Reuters) - A new type of cervical cancer vaccine made by Inovio Pharmaceuticals has shown early promise as a potential treatment for pre-cancerous changes in the cervix, researchers at ... Read more
Immunomedics finds new use for lead compound: Graft-Versus-Host Disease treatment

Immunomedics finds new use for lead compound: Graft-Versus-Host Disease treatment

October 9, 2012 12:03 pm by | 0 Comments

Immunomedics (NASDAQ: IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced the publication ... Read more
New (and better) buyout offer for Cold-EEZE maker ProPhase Labs

New (and better) buyout offer for Cold-EEZE maker ProPhase Labs

October 9, 2012 7:11 am by | 0 Comments

Matrixx Initiatives announced today that it has increased its offer to acquire all of the outstanding shares of ProPhase Labs, Inc. (NASDAQ: PRPH) by 14.3% to $1.60 per share. The ... Read more
Will cash motivate people to take their heart meds? CMS is betting $4.8M it will

Will cash motivate people to take their heart meds? CMS is betting $4.8M it will

September 27, 2012 6:53 pm by | 0 Comments

Money is a powerful motivator and improving patient adherence is a long-sought goal by the healthcare industry. A University of Pennsylvania Hospital System project to reduce Medicare costs in the ... Read more
Diagnostic device uses ultrasound to assess risk of excessive bleeding, clots in clinical settings

Diagnostic device uses ultrasound to assess risk of excessive bleeding, clots in clinical settings

September 21, 2012 6:21 pm by | 0 Comments

A diagnostic device could speed up and take the guesswork out of diagnosing and guiding treatment for excessive bleeding and overactive clotting in clinical settings. A medical device company is ... Read more
Big pharma companies’ R&D collaboration could reduce drug development costs

Big pharma companies’ R&D collaboration could reduce drug development costs

September 19, 2012 5:38 pm by | 0 Comments

A group of 10 big pharma companies are collaborating in a move that could change the way clinical trials are done. One goal of the nonprofit will be to provide ... Read more
Penn med students get free iPads as universities reduce paper, add interactive textbooks

Penn med students get free iPads as universities reduce paper, add interactive textbooks

September 11, 2012 4:00 pm by | 2 Comments

A trend has been taking place at several medical schools around the country in the past couple of years: Students are being required to own iPads. Some are even giving ... Read more